Bradespar SA
BOVESPA:BRAP4
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.07
21.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
BRAP4
stock under the Base Case scenario is
23.44
BRL.
Compared to the current market price of 21.22 BRL,
Bradespar SA
is
Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Bradespar SA.
| ZA |
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
|
| BR |
|
Vale SA
BOVESPA:VALE3
|
|
| AU |
F
|
Fortescue Ltd
XMUN:FVJ
|
|
| AU |
|
Fortescue Metals Group Ltd
ASX:FMG
|
|
| US |
|
Nucor Corp
NYSE:NUE
|
|
| LU |
|
ArcelorMittal SA
AEX:MT
|
|
| IN |
|
JSW Steel Ltd
NSE:JSWSTEEL
|
|
| US |
|
Steel Dynamics Inc
NASDAQ:STLD
|
|
| IN |
|
Tata Steel Ltd
NSE:TATASTEEL
|
|
| CN |
|
Baoshan Iron & Steel Co Ltd
SSE:600019
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Bradespar SA
Balance Sheet Decomposition
Bradespar SA
| Current Assets | 532.3m |
| Cash & Short-Term Investments | 532m |
| Other Current Assets | 261k |
| Non-Current Assets | 8.7B |
| Long-Term Investments | 8.6B |
| PP&E | 927k |
| Intangibles | 4.2m |
| Other Non-Current Assets | 117.7m |
| Current Liabilities | 89.5m |
| Accrued Liabilities | 1.3m |
| Other Current Liabilities | 88.1m |
| Non-Current Liabilities | 4.1m |
| Long-Term Debt | 4.1m |
Free Cash Flow Analysis
Bradespar SA
| BRL | |
| Free Cash Flow | BRL |
Earnings Waterfall
Bradespar SA
|
Revenue
|
1.3B
BRL
|
|
Operating Expenses
|
-244.4m
BRL
|
|
Operating Income
|
1B
BRL
|
|
Other Expenses
|
79.8m
BRL
|
|
Net Income
|
1.1B
BRL
|
BRAP4 Profitability Score
Profitability Due Diligence
Bradespar SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Bradespar SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
BRAP4 Solvency Score
Solvency Due Diligence
Bradespar SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Bradespar SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BRAP4 Price Targets Summary
Bradespar SA
According to Wall Street analysts, the average 1-year price target for
BRAP4
is 21.42 BRL
with a low forecast of 17.68 BRL and a high forecast of 26.78 BRL.
Dividends
Current shareholder yield for
BRAP4 is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BRAP4
stock under the Base Case scenario is
23.44
BRL.
Compared to the current market price of 21.22 BRL,
Bradespar SA
is
Undervalued by 9%.